Comparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid Tablets

Phase 1 Completed 16 enrolled Galmed Pharmaceuticals Ltd

RandomizedCrossoverOpen-labelTreatment

Summary

This is a Phase 1 Relative Bioavailability Study Comparing The Pharmacokinetics Of Aramchol Meglumine (AM) Granules For Oral Suspension To Aramchol Free Acid (AA) 300 mg Tablets In Healthy Volunteers

Timeline

Start: 2025-02-15
Primary completion: 2025-06-15
Completion: 2025-11-17

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Aramchol free acid	Unknown	300 mg	Oral
Subject	Aramchol meglumine	Unknown	400 mg	Oral

Indications

No indication recorded.